vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Metallus Inc. (MTUS). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $308.3M, roughly 1.1× Metallus Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 4.0% vs 1.8%, a 2.3% gap on every dollar of revenue. On growth, Metallus Inc. posted the faster year-over-year revenue change (9.9% vs 2.2%).
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
GRDN vs MTUS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $336.6M | $308.3M |
| Net Profit | $13.5M | $5.4M |
| Gross Margin | 22.7% | 8.1% |
| Operating Margin | 5.3% | — |
| Net Margin | 4.0% | 1.8% |
| Revenue YoY | 2.2% | 9.9% |
| Net Profit YoY | 46.1% | 315.4% |
| EPS (diluted) | $0.21 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.6M | $308.3M | ||
| Q4 25 | $397.6M | $267.3M | ||
| Q3 25 | $377.4M | $305.9M | ||
| Q2 25 | $344.3M | $304.6M | ||
| Q1 25 | $329.3M | $280.5M | ||
| Q4 24 | — | $240.5M | ||
| Q3 24 | $314.4M | $227.2M | ||
| Q2 24 | — | $294.7M |
| Q1 26 | $13.5M | $5.4M | ||
| Q4 25 | $20.9M | $-14.3M | ||
| Q3 25 | $9.8M | $8.1M | ||
| Q2 25 | $9.0M | $3.7M | ||
| Q1 25 | $9.4M | $1.3M | ||
| Q4 24 | — | $-21.4M | ||
| Q3 24 | $-122.0M | $-5.9M | ||
| Q2 24 | — | $4.6M |
| Q1 26 | 22.7% | 8.1% | ||
| Q4 25 | 21.5% | 2.2% | ||
| Q3 25 | 19.8% | 11.4% | ||
| Q2 25 | 19.8% | 10.6% | ||
| Q1 25 | 19.5% | 7.8% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | 19.4% | 5.3% | ||
| Q2 24 | — | 8.2% |
| Q1 26 | 5.3% | — | ||
| Q4 25 | 7.7% | -7.7% | ||
| Q3 25 | 4.3% | 3.6% | ||
| Q2 25 | 3.7% | 2.8% | ||
| Q1 25 | 3.9% | 1.0% | ||
| Q4 24 | — | -10.1% | ||
| Q3 24 | -33.3% | -3.1% | ||
| Q2 24 | — | 2.1% |
| Q1 26 | 4.0% | 1.8% | ||
| Q4 25 | 5.3% | -5.3% | ||
| Q3 25 | 2.6% | 2.6% | ||
| Q2 25 | 2.6% | 1.2% | ||
| Q1 25 | 2.9% | 0.5% | ||
| Q4 24 | — | -8.9% | ||
| Q3 24 | -38.8% | -2.6% | ||
| Q2 24 | — | 1.6% |
| Q1 26 | $0.21 | $0.13 | ||
| Q4 25 | — | $-0.34 | ||
| Q3 25 | — | $0.19 | ||
| Q2 25 | — | $0.09 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $-0.46 | ||
| Q3 24 | — | $-0.13 | ||
| Q2 24 | — | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $104.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $232.4M | $683.0M |
| Total Assets | $426.9M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $64.9M | $104.0M | ||
| Q4 25 | $65.6M | $156.7M | ||
| Q3 25 | $36.5M | $191.5M | ||
| Q2 25 | $18.8M | $190.8M | ||
| Q1 25 | $14.0M | $180.3M | ||
| Q4 24 | — | $240.7M | ||
| Q3 24 | $37.2M | $254.6M | ||
| Q2 24 | — | $272.8M |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | $34.3M | $13.2M | ||
| Q2 24 | — | $13.2M |
| Q1 26 | $232.4M | $683.0M | ||
| Q4 25 | $217.9M | $686.0M | ||
| Q3 25 | $195.5M | $697.7M | ||
| Q2 25 | $179.7M | $690.0M | ||
| Q1 25 | $163.2M | $686.1M | ||
| Q4 24 | — | $690.5M | ||
| Q3 24 | $133.9M | $712.7M | ||
| Q2 24 | — | $736.3M |
| Q1 26 | $426.9M | $1.1B | ||
| Q4 25 | $412.7M | $1.1B | ||
| Q3 25 | $390.0M | $1.2B | ||
| Q2 25 | $356.3M | $1.1B | ||
| Q1 25 | $334.0M | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $348.0M | $1.1B | ||
| Q2 24 | — | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | 0.26× | 0.02× | ||
| Q2 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 0.45× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $6.1M | — | ||
| Q4 25 | $34.6M | $-1.9M | ||
| Q3 25 | $28.2M | $22.0M | ||
| Q2 25 | $19.9M | $34.8M | ||
| Q1 25 | $17.6M | $-38.9M | ||
| Q4 24 | — | $13.9M | ||
| Q3 24 | — | $-15.3M | ||
| Q2 24 | — | $8.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-37.2M | ||
| Q3 25 | $24.2M | $-6.4M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | — | $-66.4M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-32.9M | ||
| Q2 24 | — | $-5.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -13.9% | ||
| Q3 25 | 6.4% | -2.1% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | -23.7% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | — | -14.5% | ||
| Q2 24 | — | -2.0% |
| Q1 26 | — | 0.0% | ||
| Q4 25 | — | 13.2% | ||
| Q3 25 | 1.1% | 9.3% | ||
| Q2 25 | — | 5.8% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 4.8% |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 1.65× | — | ||
| Q3 25 | 2.87× | 2.72× | ||
| Q2 25 | 2.21× | 9.41× | ||
| Q1 25 | 1.86× | -29.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
